Your browser doesn't support javascript.
loading
Immune checkpoint inhibitor-induced hypophysitis: lessons learnt from a large cancer cohort.
Kotwal, Anupam; Rouleau, Samuel G; Dasari, Surendra; Kottschade, Lisa; Ryder, Mabel; Kudva, Yogish C; Markovic, Svetomir; Erickson, Dana.
Afiliación
  • Kotwal A; Division of Diabetes, Endocrinology and Metabolism; Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Rouleau SG; Division of Endocrinology, Diabetes, Metabolism, and Nutrition; Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Dasari S; Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kottschade L; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Ryder M; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kudva YC; Division of Endocrinology, Diabetes, Metabolism, and Nutrition; Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Markovic S; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Erickson D; Division of Endocrinology, Diabetes, Metabolism, and Nutrition; Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
J Investig Med ; 70(4): 939-946, 2022 04.
Article en En | MEDLINE | ID: mdl-34969937

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipofisitis / Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipofisitis / Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article